Cancer Clinical Decision Tools Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Growth Rate of the Cancer Clinical Decision Tools Market Shape Industry Trends by 2034?
In recent years, the market size for cancer clinical decision tools has seen substantial growth. The market, which was valued at $0.5 billion in 2024, is predicted to move up to $0.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.5%. The profound growth experienced during this historical period can be credited to the rising cases of cancer, the escalating complication of cancer treatments, the swelling demand for personalized medicine, the increase in value-based healthcare adoption, the growing accessibility of cancer-related data, and government endorsements for cancer research and advancements.
In the upcoming years, the market size of cancer clinical decision tools is projected to witness robust growth. The market valuation is expected to reach $0.79 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.8%. The predicted growth during the forecast period could be linked to the worldwide aging population, enhanced patient involvement and collective decision-making, patient-oriented care, clinical studies, and evidence-supported medicine. Future trends potentially influencing this market growth could be developments in medical imaging, AI-predicted clinical decision support, telemedicine coupled with distance consultations, predictive analytics, unification and data norms, along with moral and regulatory considerations.
How Are the key drivers expanding the growth of the Cancer Clinical Decision Tools Market?
The global spike in cancer cases is expected to fuel the expansion of the cancer clinical decision tools market. As per the American Cancer Society’s report in January 2022, it is predicted that about 1.9 million new cancer diagnoses and 609,360 cancer-related deaths will occur in the US alone, averaging out to about 1,670 deaths daily. Lung, prostate, bowel, and female breast cancer are the four most prevalent cancer types globally, making up 43% of all new cases. Hence, the escalating cancer prevalence globally will enhance the need for cancer clinical decision tools. These tools can expedite the treatment decision process, thereby boosting the growth of the cancer clinical decision tools market.
Get Your Free Sample of the Global Cancer Clinical Decision Tools Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3463&type=smp
Who Are the Key Market Players Influencing the Growth of the Cancer Clinical Decision Tools Industry?
Major companies operating in the cancer clinical decision tools market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers AG, Elsevier B.V., Macmillan Publishers Limited, National Decision Support Company, Cerner Corporation, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, RaySearch Laboratories AB, Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, F. Hoffmann-La Roche Ltd., Flatiron Health Inc., Tempus Labs Inc., NantHealth Inc., Syapse Inc., Inspirata Inc., Oncora Medical Inc., Prognos Health Inc., Deep 6 AI Inc., PathAI Inc., Enlitic Inc., Ibex Medical Analytics Ltd., Zebra Medical Vision Ltd., Aidoc Medical Ltd.
What Impact Are Industry Trends Having on the Cancer Clinical Decision Tools Market’s Future Prospects?
Leading firms in the cancer clinical decision tools market, are uncovering novel products like the BenchMark Ultra Plus tissue staining system to stay ahead in the competition. This system enhances tissue staining for quicker and more precise pathology outcomes. For instance, in June 2022, F. Hoffmann-La Roche AG, a Swiss healthcare firm, released the BenchMark Ultra Plus tissue staining system. This system outshines with increased workflow efficacy, advanced testing procedures, and sustainability attributes. It enables pathologists to provide top-notch, timely findings to healthcare experts and patients. The BenchMark Ultra Plus system is the progressive step in the evolution of the BenchMark series; it automates the traditionally manual slide-by-slide actions, bringing a new wave in cancer diagnostics.
Get Instant Access to the Global Cancer Clinical Decision Tools Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report
How Are the Key Segments of the Cancer Clinical Decision Tools Market Driving Opportunities and Innovations?
The cancer clinical decision tools market covered in this report is segmented –
1) By Type: Risk Assessment Tool(RAT), Qcancer
2) By End-User: Hospital, Clinics
Subsegments:
1) By Risk Assessment Tool (RAT): Family History Assessment, Genetic Testing and Counseling, Lifestyle and Environmental Risk Factors Evaluation
2) By Qcancer: Symptom Checker, Risk Calculator, Guideline-Based Recommendations
Which Regions Are Emerging as Leaders in the Cancer Clinical Decision Tools Market?
The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Are the Defining Features of the Cancer Clinical Decision Tools Market?
Cancer clinical decision tools refer to the tools that are developed to help medical practitioners identify suspected cancer signs and symptoms and treat patients effectively. These tools aid in clinical decision-making by assisting GPs in deciding whether to refer or seek additional diagnostic testing in patients suspected of having cancer.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Diagnostic Equipment Global Market Report 2024
Rapid Microbiology Testing Kits Global Market Report 2024
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
